ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,383,565, issued on Aug. 12, was assigned to Oculis Operations Sarl (Lausanne, Switzerland).

"Treatment of diabetic retinopathy with ophthalmic compositions" was invented by Thorsteinn Loftsson (Reykjavik, Iceland) and Zoltan Fulop (Budapest, Hungary).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to a method for stabilizing the pH of an aqueous composition comprising a drug which is prone to oxidation, said method comprising the addition of an additive to prevent oxidation of the drug which is prone to oxidation. In particular, the present disclosure relates to a method for stabilizing the pH of an aqueous composition compr...